A J Bitonti

Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity.

J A Dumont, A J Bitonti, Christine Wallace et al. · PubMed · 1996 · 89 citations

Mcf-wes Cells, Breast Oncology, Elevated Levels +15

Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.

A J Bitonti, Jennifer Dumont, Trudy L. Bush et al. · PubMed · 1994 · 39 citations

Mdl 101,731, Breast Oncology, Oncology +14

In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor.

J Piepmeier, Nicole Rabidou, S C Schold et al. · PubMed · 1996 · 23 citations

Chemoprevention Strategy, Xenograft Models, High-grade Gliomas +19